UNSPSC 85254900: Diagnoses of peripheral benign neoplasms of skin

This classification denotes the group of activities that yields a diagnosis of peripheral benign neoplasms of skin

UNSPSC 85254900 Diagnoses of peripheral benign neoplasms of skin is a Class code that shows minimal alignment between its nominal scope and recent state and local procurement activity. The code's specific clinical focus on skin neoplasm diagnosis does not match the three opportunities posted in the recent-opportunities block. Those solicitations instead address diagnostic imaging infrastructure (PACS systems), special education contracted services (speech therapists, occupational therapists, audiologists, and related disciplines), and temporary health professional staffing across ancillary clinical categories including audiology, diagnostic imaging, therapy services, and patient transport. None of these opportunities centers on skin pathology diagnosis or dermatological screening. The state and local procurement activity tagged under this code appears to reflect a data-quality issue in the source system rather than genuine buying activity aligned with peripheral benign neoplasm diagnosis services.

The three opportunities originate from California counties (San Mateo and Santa Clara) and a Texas independent school district, with response dates in October 2026. The San Mateo Medical Center RFP, due October 21, 2026, seeks a diagnostic imaging PACS with EPIC integration to support 65,000 annual radiology studies and other modalities. Santa Clara Health System's qualification vehicle, also due October 7, 2026, establishes a non-exclusive vendor pool for temporary staffing in 13 ancillary clinical categories over five years. Birdville Independent School District's competitive sealed proposal, due October 21, 2026, covers 23 line items of special education services including speech pathology, occupational therapy, and psychology support across 30 campuses. The code does not show meaningful recent procurement activity aligned with its stated clinical purpose and warrants reassessment or reclassification in the source system.